The pharmaceutical company has committed $840,000 to Boryung D:HealthCovery, which will work with accelerator Invention Lab.

Alibaba's financial services spinoff has officially filed for a dual listing in Shanghai and Hong Kong that could potentially raise $30bn.

China's State Development and Investment Corporation has picked up an 18.6% stake in Sihuan Pharmaceutical’s drug development spinoff, Xuanzhu Biopharmaceutical.

Lilly Asia Ventures was among the new investors in a series C round for autoimmune and inflammatory disease drug developer Connect Biopharma.

The predictive logistics platform developer has raised a further $13m, adding to $24.5m raised from investors including M12 and Honeywell Ventures in April.

The medical data software producer has filed to float in Hong Kong after raising nearly $340m from investors including Tencent and Sunshine Insurance.

The SK Telecom, iA Financial, Foxconn and Fujifilm-backed X-ray technology developer priced the offering at the top of its range.

Takasago Thermal Engineering and Mitsui Sumitomo Insurance made strategic investments in the moon exploration business, which has now raised $125m in total.

Samsung Ventures and Fosun RZ Capital contributed to an $11.4m round that lifestyle media app developer Trell will put into hiring and product development.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.